Summary slide.png (112.94 kB)
Download fileA Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?
figure
posted on 2020-06-04, 08:18 authored by Jie Zhang, Junlong Li, Qiufei Ma, Hongbo Yang, James Signorovitch, Eric WuThe above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.